Coal India's fuel allocation under spot e-auction rises 59% during April-November

Fuel allocation by CIL under the scheme also increased to 4.09 MT in November, from over 3.58 MT in the corresponding month of 2019.

PTI

December 21, 2020 / 10:03 PM IST

Source: reuters

State-owned CIL allocated 25.78 million tonnes (MT) of coal in the first eight months of this fiscal under spot e-auction scheme, registering a year-on-year increase of 59.4 per cent. Coal India Ltd (CIL) had allocated 16.17 MT of coal in the April-November period of the previous fiscal, according to government data.

Fuel allocation by CIL under the scheme also increased to 4.09 MT in November, from over 3.58 MT in the corresponding month of 2019. Coal distribution through e-auction was introduced to provide access to coal for such buyers who are not able to source the dry fuel through the available institutional mechanism, according to CIL's website.

Coal India aims at substituting 80-85 mt of imported fuel in FY'21

The purpose of e-auction is to provide equal opportunity to all intending buyers for purchasing coal through single window service. Coal India accounts for over 80 per cent of domestic coal output.

CIL has revised its production target to 650-660 MT for the current fiscal in the wake of the disruptions caused by the COVID-19 pandemic. The miner had earlier set a production target of 710 MT for the 2020-21 fiscal.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show